CRi Announces Breakthrough in Multispectral Imaging System

Cambridge Research & Instrumentation, Inc. (CRi) announces the launch of Nuance 2, the affordable, breakthrough system that converts any brightfield or fluorescent microscope into a multispectral imaging workstation. For multispectral imaging analysis of a larger specimens, such as embryos, zebrafish, plants, tissue culture and microtiter plates, the Nuance 2 can be mounted onto a fluorescent macroscope. The Nuance 2 system will be showcased at the upcoming San Antonio Breast Cancer Symposium from December 13th through December 16th in San Antonio, Texas.

The sleekly designed Nuance 2 features new analytical software providing the user with enhanced spectral unmixing tools and more efficient CCD cooling for better low-light imaging. Spectral library building is now easier, using the Real Component Analysis(TM) (RCA) algorithm to automatically identify spectral signatures and the new Compute Spectra(TM) feature to properly identify true spectral signatures when combined or overlapping. Nuance sensitivity has been improved allowing discrimination of co-localized markers, even when present in different amounts, and reports the relative amounts of each marker and the percentage of each co-localized marker within the sample. At the heart of the Nuance 2 is the Flex(TM) liquid crystal tunable filter (LCTF) which provides fast, accurate spectral imaging from 420 to 720 nm (VIS model) and 500 to 950 nm (GNIR model), covering the full range of available chromogenic dyes and in vitro fluorophores.

"We are very excited about the Nuance 2 Multispectral Imaging System," says James Mansfield, Director of Multispectral Imaging Systems at CRi. "From its new industrial design, optimized optics and user-friendly software tools, this system was designed and developed with the customers' needs in mind. Along with our award winning Maestro(TM) In Vivo imaging systems, CRi offers a full spectrum of imaging solutions for our customers."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.